Orphan nuclear receptor NR4A1 regulates transforming growth factor-beta signaling and fibrosis
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10294722" target="_blank" >RIV/00216208:11110/15:10294722 - isvavai.cz</a>
Alternative codes found
RIV/00023728:_____/15:#0005052
Result on the web
<a href="http://dx.doi.org/10.1038/nm.3777" target="_blank" >http://dx.doi.org/10.1038/nm.3777</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1038/nm.3777" target="_blank" >10.1038/nm.3777</a>
Alternative languages
Result language
angličtina
Original language name
Orphan nuclear receptor NR4A1 regulates transforming growth factor-beta signaling and fibrosis
Original language description
Mesenchymal responses are an essential aspect of tissue repair. Failure to terminate this repair process correctly, however, results in fibrosis and organ dysfunction. Therapies that block fibrosis and restore tissue homeostasis are not yet available forclinical use. Here we characterize the nuclear receptor NR4A1 as an endogenous inhibitor of transforming growth factor-beta (TGF-beta) signaling and as a potential target for anti-fibrotic therapies. NR4A1 recruits a repressor complex comprising SP1, SIN3A, CoREST, LSD1, and HDAC1 to TGF-beta target genes, thereby limiting pro-fibrotic TGF-beta effects. Even though temporary upregulation of TGF-beta in physiologic wound healing induces NR4A1 expression and thereby creates a negative feedback loop, thepersistent activation of TGF-beta signaling in fibrotic diseases uses AKT- and HDAC-dependent mechanisms to inhibit NR4A1 expression and activation. Small-molecule NR4A1 agonists can overcome this lack of active NR4A1 and inhibit experime
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FE - Other fields of internal medicine
OECD FORD branch
—
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Nature Medicine
ISSN
1078-8956
e-ISSN
—
Volume of the periodical
21
Issue of the periodical within the volume
2
Country of publishing house
US - UNITED STATES
Number of pages
9
Pages from-to
150-158
UT code for WoS article
000348974800017
EID of the result in the Scopus database
2-s2.0-84925537240